238 related articles for article (PubMed ID: 37275893)
21. Regulation of human neutrophil Fcγ receptor IIa by C5a receptor promotes inflammatory arthritis in mice.
Tsuboi N; Ernandez T; Li X; Nishi H; Cullere X; Mekala D; Hazen M; Köhl J; Lee DM; Mayadas TN
Arthritis Rheum; 2011 Feb; 63(2):467-78. PubMed ID: 21280001
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
Hashimoto T; Ishii N; Ohata C; Furumura M
J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
[TBL] [Abstract][Full Text] [Related]
23. Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation.
Miyabe Y; Miyabe C; Mani V; Mempel TR; Luster AD
Sci Immunol; 2019 May; 4(35):. PubMed ID: 31076525
[TBL] [Abstract][Full Text] [Related]
24. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
25. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita.
Guerrero-Juarez CF; Schilf P; Li J; Zappia MP; Bao L; Patel PM; Gieseler-Tillmann J; Murthy S; Cole C; Sverdlov M; Frolov MV; Hashimoto T; Ishii N; Rülicke T; Bieber K; Ludwig RJ; Sadik CD; Amber KT
Front Immunol; 2023; 14():1266359. PubMed ID: 37799716
[TBL] [Abstract][Full Text] [Related]
26. Role of the C5a-C5a receptor axis in the inflammatory responses of the lungs after experimental polytrauma and hemorrhagic shock.
Chakraborty S; Winkelmann VE; Braumüller S; Palmer A; Schultze A; Klohs B; Ignatius A; Vater A; Fauler M; Frick M; Huber-Lang M
Sci Rep; 2021 Jan; 11(1):2158. PubMed ID: 33495506
[TBL] [Abstract][Full Text] [Related]
27. Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2.
Karsten CM; Beckmann T; Holtsche MM; Tillmann J; Tofern S; Schulze FS; Heppe EN; Ludwig RJ; Zillikens D; König IR; Köhl J; Schmidt E
Front Immunol; 2018; 9():488. PubMed ID: 29599777
[TBL] [Abstract][Full Text] [Related]
28. Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury.
Kasperkiewicz M; Nimmerjahn F; Wende S; Hirose M; Iwata H; Jonkman MF; Samavedam U; Gupta Y; Möller S; Rentz E; Hellberg L; Kalies K; Yu X; Schmidt E; Häsler R; Laskay T; Westermann J; Köhl J; Zillikens D; Ludwig RJ
J Pathol; 2012 Sep; 228(1):8-19. PubMed ID: 22430937
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.
Karsten CM; Pandey MK; Figge J; Kilchenstein R; Taylor PR; Rosas M; McDonald JU; Orr SJ; Berger M; Petzold D; Blanchard V; Winkler A; Hess C; Reid DM; Majoul IV; Strait RT; Harris NL; Köhl G; Wex E; Ludwig R; Zillikens D; Nimmerjahn F; Finkelman FD; Brown GD; Ehlers M; Köhl J
Nat Med; 2012 Sep; 18(9):1401-6. PubMed ID: 22922409
[TBL] [Abstract][Full Text] [Related]
30. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
[TBL] [Abstract][Full Text] [Related]
31. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
[TBL] [Abstract][Full Text] [Related]
32. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
[TBL] [Abstract][Full Text] [Related]
33. Complement C5a-Induced Changes in Neutrophil Morphology During Inflammation.
Denk S; Taylor RP; Wiegner R; Cook EM; Lindorfer MA; Pfeiffer K; Paschke S; Eiseler T; Weiss M; Barth E; Lambris JD; Kalbitz M; Martin T; Barth H; Messerer DAC; Gebhard F; Huber-Lang MS
Scand J Immunol; 2017 Sep; 86(3):143-155. PubMed ID: 28671713
[TBL] [Abstract][Full Text] [Related]
34. C5a initiates the inflammatory cascade in immune complex peritonitis.
Godau J; Heller T; Hawlisch H; Trappe M; Howells E; Best J; Zwirner J; Verbeek JS; Hogarth PM; Gerard C; Van Rooijen N; Klos A; Gessner JE; Köhl J
J Immunol; 2004 Sep; 173(5):3437-45. PubMed ID: 15322209
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
Zaal A; van Ham SM; Ten Brinke A
Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
[TBL] [Abstract][Full Text] [Related]
36. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
Pundir P; MacDonald CA; Kulka M
J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
[TBL] [Abstract][Full Text] [Related]
37. The role of C5a receptors in autoimmunity.
Schanzenbacher J; Hendrika Kähler K; Mesler E; Kleingarn M; Marcel Karsten C; Leonard Seiler D
Immunobiology; 2023 Sep; 228(5):152413. PubMed ID: 37598588
[TBL] [Abstract][Full Text] [Related]
38. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
Das A; Ghosh M; Gupta PK; Rana S
J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
[TBL] [Abstract][Full Text] [Related]
39. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
[TBL] [Abstract][Full Text] [Related]
40. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
